Academic literature on the topic 'Epidemiology, health economics, cost-of-illness, respiratory diseases'

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Epidemiology, health economics, cost-of-illness, respiratory diseases.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Epidemiology, health economics, cost-of-illness, respiratory diseases"

1

Sandora, Thomas J., Courtney A. Gidengil, and Grace M. Lee. "Pertussis Vaccination for Health Care Workers." Clinical Microbiology Reviews 21, no. 3 (2008): 426–34. http://dx.doi.org/10.1128/cmr.00003-08.

Full text
Abstract:
SUMMARY Pertussis, an acute respiratory infection caused by Bordetella pertussis, classically manifests as a protracted cough illness. The incidence of pertussis in the United States has been increasing in recent years. Immunity wanes after childhood vaccination, leaving adolescents and adults susceptible to infection. The transmission of pertussis in health care settings has important medical and economic consequences. Acellular pertussis booster vaccines are now available for use and have been recommended for all adolescents and adults. These vaccines are safe, immunogenic, and effective. He
APA, Harvard, Vancouver, ISO, and other styles
2

López-Bastida, J. "Health Economics: the Cost of Illness and Economic Evaluation in Respiratory Diseases." Archivos de Bronconeumología ((English Edition)) 42, no. 5 (2006): 207–10. http://dx.doi.org/10.1016/s1579-2129(06)60447-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Dawood, Fatimah S., Shikha Garg, Rebecca V. Fink, et al. "Epidemiology and Clinical Outcomes of Hospitalizations for Acute Respiratory or Febrile Illness and Laboratory-Confirmed Influenza Among Pregnant Women During Six Influenza Seasons, 2010–2016." Journal of Infectious Diseases 221, no. 10 (2019): 1703–12. http://dx.doi.org/10.1093/infdis/jiz670.

Full text
Abstract:
Abstract Background Pregnant women are at increased risk of seasonal influenza hospitalizations, but data about the epidemiology of severe influenza among pregnant women remain largely limited to pandemics. Methods To describe the epidemiology of hospitalizations for acute respiratory infection or febrile illness (ARFI) and influenza-associated ARFI among pregnant women, administrative and electronic health record data were analyzed from retrospective cohorts of pregnant women hospitalized with ARFI who had testing for influenza viruses by reverse-transcription polymerase chain reaction (RT-PC
APA, Harvard, Vancouver, ISO, and other styles
4

CHEN, S. C., and C. M. LIAO. "Cost-effectiveness of influenza control measures: a dynamic transmission model-based analysis." Epidemiology and Infection 141, no. 12 (2013): 2581–94. http://dx.doi.org/10.1017/s0950268813000423.

Full text
Abstract:
SUMMARYWe investigated the cost-effectiveness of different influenza control strategies in a school setting in Taiwan. A susceptible-exposure-infected-recovery (SEIR) model was used to simulate influenza transmission and we used a basic reproduction number (R0)–asymptomatic proportion (θ) control scheme to develop a cost-effectiveness model. Based on our dynamic transmission model and economic evaluation, this study indicated that the optimal cost-effective strategy for all modelling scenarios was a combination of natural ventilation and respiratory masking. The estimated costs were US$10/year
APA, Harvard, Vancouver, ISO, and other styles
5

Murphy, Adrianna, Benjamin Palafox, Marjan Walli-Attaei, et al. "The household economic burden of non-communicable diseases in 18 countries." BMJ Global Health 5, no. 2 (2020): e002040. http://dx.doi.org/10.1136/bmjgh-2019-002040.

Full text
Abstract:
BackgroundNon-communicable diseases (NCDs) are the leading cause of death globally. In 2014, the United Nations committed to reducing premature mortality from NCDs, including by reducing the burden of healthcare costs. Since 2014, the Prospective Urban and Rural Epidemiology (PURE) Study has been collecting health expenditure data from households with NCDs in 18 countries.MethodsUsing data from the PURE Study, we estimated risk of catastrophic health spending and impoverishment among households with at least one person with NCDs (cardiovascular disease, diabetes, kidney disease, cancer and res
APA, Harvard, Vancouver, ISO, and other styles
6

Tempia, Stefano, Jocelyn Moyes, Adam L. Cohen, et al. "Health and economic burden of influenza‐associated illness in South Africa, 2013‐2015." Influenza and Other Respiratory Viruses 13, no. 5 (2019): 484–95. http://dx.doi.org/10.1111/irv.12650.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Graves, Nicholas, Tanya M. Nicholls, and Arthur J. Morris. "Modeling the Costs of Hospital-Acquired Infections in New Zealand." Infection Control & Hospital Epidemiology 24, no. 3 (2003): 214–23. http://dx.doi.org/10.1086/502192.

Full text
Abstract:
AbstractObjective:To model the economic costs of hospital-acquired infections (HAIs) in New Zealand, by type of HAI.Design:Monte Carlo simulation model.Setting:Auckland District Health Board Hospitals (DHBH), the largest publicly funded hospital group in New Zealand supplying secondary and tertiary services. Costs are also estimated for predicted HAIs in admissions to all hospitals in New Zealand.Patients:All adults admitted to general medical and general surgical services.Method:Data on the number of cases of HAI were combined with data on the estimated prolongation of hospital stay due to HA
APA, Harvard, Vancouver, ISO, and other styles
8

Restrepo, Marcos I., Antonio Anzueto, Alejandro C. Arroliga, et al. "Economic Burden of Ventilator-Associated Pneumonia Based on Total Resource Utilization." Infection Control & Hospital Epidemiology 31, no. 05 (2010): 509–15. http://dx.doi.org/10.1086/651669.

Full text
Abstract:
Objectives. To characterize the current economic burden of ventilator-associated pneumonia (VAP) and to determine which services increase the cost of VAP in North American hospitals. Design and Setting. We performed a retrospective, matched cohort analysis of mechanically ventilated patients enrolled in the North American Silver-Coated Endotracheal Tube (NASCENT) study, a prospective, randomized study conducted from 2002 to 2006 in 54 medical centers, including 45 teaching institutions (83.3%). Methods. Case patients with microbiologically confirmed VAP (n = 30) were identified from 542 study
APA, Harvard, Vancouver, ISO, and other styles
9

Abdelzaher, Amir M., Mary E. Wright, Cristina Ortega, et al. "Daily measures of microbes and human health at a non-point source marine beach." Journal of Water and Health 9, no. 3 (2011): 443–57. http://dx.doi.org/10.2166/wh.2011.146.

Full text
Abstract:
Studies evaluating the relationship between microbes and human health at non-point source beaches are necessary for establishing criteria which would protect public health while minimizing economic burdens. The objective of this study was to evaluate water quality and daily cumulative health effects (gastrointestinal, skin, and respiratory illnesses) for bathers at a non-point source subtropical marine recreational beach in order to better understand the inter-relationships between these factors and hence improve monitoring and pollution prevention techniques. Daily composite samples were coll
APA, Harvard, Vancouver, ISO, and other styles
10

Kolosov, V. P., O. P. Kurganova, J. M. Perelman, et al. "Analysis of medical and economic efficiency of vaccine prevention of respiratory diseases among builders of the Amur Gas Processing Plant using expert assessments and methods of predictive modeling." Bulletin Physiology and Pathology of Respiration, no. 85 (September 21, 2022): 8–18. http://dx.doi.org/10.36604/1998-5029-2022-85-8-18.

Full text
Abstract:
Introduction. Acute respiratory viral and pneumococcal infections, the incidence of which is associated with high economic costs, are one of the most important problems in epidemiology and pulmonology. Preventive vaccination is a tool for managing the incidence of acute respiratory viral infection (ARVI) and pneumococcal infections. The issues of medical and economic efficiency of preventive vaccination are constantly in the field of epidemiological surveillance, and the estimates obtained in this case are a necessary condition for making decisions on the viability of investing in its organiza
APA, Harvard, Vancouver, ISO, and other styles
More sources
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!